CERN Experiment Produces First Beam of Antihydrogen Atoms for Hyperfine Study
GENEVA — For the first time, the ASACUSA experiment at CERN has succeeded in producing a beam of antihydrogen atoms. In a paper published January 21, 2014, in Nature Communications, the ASACUSA collaboration reports the unambiguous detection of 80 antihydrogen atoms 2.7 meters downstream of their production, where the perturbing influence of the magnetic fields used initially to produce the antiatoms is small. This result is a significant step towards precise hyperfine spectroscopy of antihydrogen atoms.
Primordial antimatter has so far never been observed in the Universe, and its absence remains a major scientific enigma. Nevertheless, it is possible to produce significant amounts of antihydrogen in experiments at CERN by mixing antielectrons (positrons) and low energy antiprotons produced by the Antiproton Decelerator.
The spectra of hydrogen and antihydrogen are predicted to be identical, so any tiny difference between them would immediately open a window to new physics, and could help in solving the antimatter mystery. With its single proton accompanied by just one electron, hydrogen is the simplest existing atom, and one of the most precisely investigated and best understood systems in modern physics. Thus comparisons of hydrogen and antihydrogen atoms constitute one of the best ways to perform highly precise tests of matter/antimatter symmetry.
Matter and antimatter annihilate immediately when they meet, so aside from creating antihydrogen, one of the key challenges for physicists is to keep antiatoms away from ordinary matter. To do so, experiments take advantage of antihydrogen’s magnetic properties (which are similar to hydrogen’s) and use very strong non-uniform magnetic fields to trap antiatoms long enough to study them. However, the strong magnetic field gradients degrade the spectroscopic properties of the (anti)atoms. To allow for clean high-resolution spectroscopy, the ASACUSA collaboration developed an innovative set-up to transfer antihydrogen atoms to a region where they can be studied in flight, far from the strong magnetic field.
“Antihydrogen atoms having no charge, it was a big challenge to transport them from their trap. Our results are very promising for high-precision studies of antihydrogen atoms, particularly the hyperfine structure, one of the two best known spectroscopic properties of hydrogen. Its measurement in antihydrogen will allow the most sensitive test of matter/antimatter symmetry. We are looking forward to restarting this summer with an even more improved set-up,” said Yasunori Yamazaki of RIKEN, Japan, a team leader of the ASACUSA collaboration.
The next step for the ASACUSA experiment will be to optimize the intensity and kinetic energy of antihydrogen beams, and to understand better their quantum state.
Progress with antimatter experiments at CERN has been accelerating in recent years. In 2011, the ALPHA experiment announced trapping of antihydrogen atoms for 1000 seconds and reported observation of hyperfine transitions of trapped antiatoms in 2012. In 2013, the ATRAP experiment announced the first direct measurement of the antiproton’s magnetic moment with a fractional precision of 4.4 parts in a million.
ASACUSA is an experiment at CERN's Antiproton Decelerator (AD) facility studying the properties of antimatter. The main thrust of ASACUSA's research program has been the study of antihydrogen as well as exotic atoms known as antiprotonic helium. (Antiprotonic helium consists of an antiproton and an electron orbiting around the helium nucleus). The antihydrogen experiment (the CUSP group) aims at high precision microwave spectroscopy of hyperfine transitions in a weak magnetic field region. In total, five experiments use the AD's low energy antiproton beams, and two more are coming, BASE and Gbar. ALPHA and ATRAP focus on studying antihydrogen atoms. AEgIS, an experiment under construction, will study the influence of gravity on antimatter, while ACE is an experiment investigating the effectiveness of antiprotons as a potential treatment for certain forms of cancer.
CERN, the European Organization for Nuclear Research, is the world's leading laboratory for particle physics. It has its headquarters in Geneva. At present, its member states are Austria, Belgium, Bulgaria, the Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Israel, Italy, the Netherlands, Norway, Poland, Portugal, Slovakia, Spain, Sweden, Switzerland and the United Kingdom. Romania is a Candidate for Accession. Serbia is Associate member in the pre-stage to membership. India, Japan, the Russian Federation, the United States of America, Turkey, the European Commission and UNESCO have observer status.